Related Experiment Videos

Inhibition of wound contraction by topical antimicrobials

I O Leitch1, A Kucukcelebi, M C Robson

  • 1Department of Plastic and Reconstructive Surgery, Royal Adelaide Hospital, Australia.

Insights

Topical antimicrobials silver sulfadiazine and mafenide acetate disrupt fibroblast function. This disruption significantly impedes spontaneous wound contraction and healing in vivo.

Area of Science:

  • Wound healing research
  • Dermatology
  • Pharmacology

Background:

  • Spontaneous wound healing relies on fibroblast function, including collagen production and wound contraction.
  • Topical antimicrobials like silver sulfadiazine and mafenide acetate are commonly used for wound care.
  • Previous in vitro studies suggested these antimicrobials may disrupt fibroblast activity.

Purpose of the Study:

  • To investigate the in vivo effects of silver sulfadiazine and mafenide acetate on wound contraction.
  • To determine if topical antimicrobial application impedes the natural wound healing process.

Main Methods:

  • An acute wound model was established in rats.
  • The impact of topical silver sulfadiazine and mafenide acetate on wound contraction was assessed in vivo.

Main Results:

  • Silver sulfadiazine and mafenide acetate significantly impeded wound contraction in the rat model.
  • The findings suggest these antimicrobials interfere with fibroblast-mediated wound closure.

Conclusions:

  • Topical silver sulfadiazine and mafenide acetate can negatively affect wound healing by impairing wound contraction.
  • Further research is warranted to explore alternative wound care strategies that preserve fibroblast function.

Related Concept Videos